Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 668 participants.
Also called NCT04886388
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 668 participants
- Sponsor
- Better Therapeutics
- Registry
-
NCT04886388
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04886388. Randomized; no masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2022-03-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Device)
- BT-001
- Intervention (Other)
- Physician-guided Standard of Care for type 2 diabetes
- Lead sponsor
- Better Therapeutics
Record details
- Record id
cardio:ct-nct04886388- Content hash
69899c39c4d3428a31260749dd42b1a54c64bec580577da88a674a5a9cf1cd2c